Abstract
Asthma is recognized as chronic airway inflammation characterized by airway eosinophilic inflammation and airway hyperreactivity (1). It is also highly correlated with atopy, and antigen-induced immunoglobulin E (IgE) production is increased in patients with allergic asthma (2). Interleukin-5 (IL-5) is the terminal differentiation, activation, and survival factor for eosinophils (3,4). IL-4 amplifies the asthmatic inflammatory response through IgE class switching (5) and stimulating growth of mast cells (6). IL-13 also plays a role in IgE synthesis (7). CD4-positive T lymphocytes can be divided in to type 1 helper T (Th1) and type 2 helper T (Th2) cells on the basis of their cytokine production pattern (8). Th2 cells can produce IL-4, IL-5, and IL-13. Therefore, although mast cells and eosinophils also can secrete these cytokines (9,10), Th2 cells are seen as having a central role for pathogenesis of asthma since they produce these proinflammatory mediators in antigenspecific responses (11). Th 1 cells produce IL-2 and interferon γ (IFN-γ) and none of the Th2 cytokines. Th1 and Th2 cells are counter-regulatory through their cytokine production. For example, IL-4 promotes Th2 development (12) and inhibits Th 1 cells (13). In contrast, IFN-y promotes Th1 development (12) and inhibits the proliferation of Th2 cells (14) and the synthesis of IL-4 and IL-5 by Th2 cells (15). Th1 and Th2 cells have been identified in humans (16–18). These lines of evidences suggest that inhibition of Th2 cytokine production or enhancement of Th1 cytokine production may be useful in the treatment of asthma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
National Asthma Education and Prevention Program. (1997) Expert panel report2: guidelines for the diagnosis and management of asthma. National Institutes of Health, MD, Publication No. 97–4051.
Romagnani, S. (2000) The role of lymphocytes in allergic disease. J. Allergy Clin. Immunol. 105, 399–408.
Yamaguchi, Y., T. Suda, S. Ohta, K. Tominaga, Y. Miura, and T. Kasahara. (1991) Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood 78, 2542–2547.
Yamaguchi, Y., T. Suda, J. Suda, M. et al. (1988) Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 167, 43–56.
Del Prete, G., E. Maggi, P. Parronchi, I. et al. (1988) IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J. Immunol. 140, 4193–4198.
Saito, H., K. Hatake, A. M., Dvorak, K. M. et al. (1988) Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins. Proc. Natl. Acad. Sci. USA 85, 2288–2292.
Punnonen, J., G. Aversa, B. G. Cocks, A. N. et al. (1993) Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 90, 3730–3734.
Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. (1986) Two types of murine helper T cell clone. I. Definition accord- ing to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348–2357.
Okayama, Y., C. Petit-Frere, O. Kassel, A. et al. (1995) IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. J. Immunol. 155, 1796–1808.
Alam, R., P. Forsythe, S. Stafford, and Y. Fukuda. (1994) Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J. Exp. Med. 179, 1041–1045.
Kay, A. B. (1996) TH2-type cytokines in asthma. Ann N YAcad. Sci. 796, 1–8.
Swain, S. L., Weinberg, A. D. English, M. and Huston, G. (1990) IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145, 3796–3806.
Parronchi, P. M., De Carli, R. Manetti, C. et al. (1992) IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th 1 or Th2 human T cell clones. J. Immunol. 149, 2977–2983.
Gajewski, T. F. and Fitch, F. W. (1988) Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN- gamma inhibits the proliferation of Th2 but not Th l murine helper T lymphocyte clones. J. Immunol. 140.4245–4252.
Trinchieri, G. (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251–276.
Wierenga, E. A., M. Snoek, C. de Groot, I. et al. (1990) Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients. J. Immunol. 144, 4651–4656.
Del Prete, G. F., De Carli, M., Mastromauro, C. et al. (1991) Purified protein derivative of Mycobacterium tuberculosis and excretory- secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 88, 346–350.
Romagnani, S. (1991) Human TH1 and TH2 subsets: doubt no more. Immunol. Today 12, 256–257.
Drazen, J. M., Israel, E. and O’ Byrne, P. M. (1999) Treatment of asthma with drugs modifying the leukotriene pathway. N. Engl. J. Med. 340, 197–206.
Barnes, P. J. (1998) Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci. (Colch) 94, 557–572.
Arya, S.K.,Wong-Staal, F. and Gallo, R. C. (1984) Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA. J. Immunol. 133, 273–276.
Smith, D. H., Malone, D. C., Lawson, K. A., Okamoto, L. J., Battista, C. and Saunders, W. B. (1997) A national estimate of the economic costs of asthma. Am. J. Respir. Crit. Care Med. 156, 787–793.
Evans, R., 3rd, Mullally, D. I., Wilson, R. W., et al. (1987) National trends in the morbidity and mortality of asthma in the US. Prevalence, hospitalization and death from asthma over two decades: 1965–1984. Chest. 91, 65S-74S.
Krieg, A. M., Yi, A. K., Matson, S. et al. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546–549.
Bird, A. P. (1986) CpG-rich islands and the function of DNA methylation. Nature 321, 209–213.
Fynan, E. F., Webster, R. G., Fuller, D. H. Haynes, J. R. Santoro, J. C. and Robinson, H. L. (1993) DNA vaccines: protective immunizations by parenteral, mucosal, and gene- gun inoculations. Proc. Natl. Acad. Sci. USA 90, 11,478–11,482.
Wang, B., Ugen, K. E., Srikantan, V. et al. (1993) Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90, 4156–4160.
Klinman, D. M., Yi, A. K., Beaucage, S. L., Conover, J. and Krieg, A. M. (1996) CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc. Natl. Acad. Sci. USA 93, 2879–2883.
Liang, H., Nishioka, Y., Reich, C. F., Pisetsky, D. S. and Lipsky, P. E. (1996) Activation of human B cells by phosphorothioate oligodeoxynucleotides. J. Clin. Invest. 98, 1119–1129.
Hemmi, H., Takeuchi, O., Kawai, T., et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408, 740–745.
Hacker, H., Mischak, H., Miethke, T., et al. (1998) CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 17, 6230–6240.
Macfarlane, D. E. and Manzel, L. (1998) Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. J. Immunol. 160, 1122–1131.
Yi, A. K., and Krieg, A. M. (1998) Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. J. Immunol. 161, 4493–4497.
Heeg, K. and Zimmermann, S. (2000) CpG DNA as a Thl trigger. Int. Arch. Allergy Immunol. 121, 87–97.
Yi, A. K. and Krieg, A. M. (1998) CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel. J. Immunol. 160, 1240–1245.
Schnare, M., Holt, A. C., Takeda, K., Akira, S., and Medzhitov, R. (2000) Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88. Curr. Biol. 10, 1139–1142.
Chace, J. H., Hooker, N. A., Mildenstein, K. L., Krieg, A. M. and Cowdery, J. S. (1997) Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12. Clin. Immunol. Immunopathol.84, 185–193.
Tascon, R. E., S. Ragno, D. B. Lowrie, and M. J. Colston. (2000) Immunostimulatory bacterial DNA sequences activate dendritic cells and promote priming and differentiation of CD8+ T cells. Immunology 99, 1–7.
Bohle, B., Jahn-Schmid, B., Maurer, D., Kraft, D. and Ebner, C. (1999) Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN- gamma production in cells from allergic individuals and inhibit IgE synthesis in vitro. Eur. J. Immunol. 29, 2344–2353.
Beasley, R., Crane, J., Lai, C. K. and Pearce, N. (2000) Prevalence and etiology of asthma. J. Allergy Clin. Immunol. 105, S466—S472.
von Mutius, E., Fritzsch, C., Weiland, S. K.,Roll, G. and Magnussen, H. (1992) Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison. Bmj 305, 1395–1399.
von Mutius, E., Martinez, F. D., Fritzsch, C., Nicolai, T., Reitmeir, P. and Thiemann, H. H. (1994) Skin test reactivity and number of siblings. Bmj 308, 692–695.
Shaheen, S. O., Aaby, P., Hall, A. J., et al. (1996) Measles and atopy in Guinea-Bissau. Lancet 347, 1792–1796.
Shirakawa, T., Enomoto, T., Shimazu, S. and Hopkin, J. M. (1997) The inverse association between tuberculin responses and atopic disorder. Science 275, 77–79.
Kline, J. N.,Waldschmidt, T. J., Businga, T. R., et al. (1998) Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J. Immunol. 160, 2555–2559.
Kline, J. N. (2000) Effects of CpG DNA on Thl /Th2 balance in asthma. Curr. Top Microbiol. Immunol. 247, 211–225.
Broide, D., Schwarze, J., Tighe, H. et al. (1998) Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J. Immunol. 161, 7054–7062.
Sur, S., Wild, J. S., Choudhury, B. K., Sur, N., Alam, R. and Klinman, D. M. (1999) Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J. Immunol. 162, 6284–6293.
Shirota, H., Sano, K., Kikuchi, T., Tamura, G. and Shirato, K. (2000) Regulation of T-helper type 2 cell and airway eosinophilia by transmucosal coadministration of antigen and oligodeoxynucleotides containing CpG motifs. Am. J. Respir. Cell Mol. Biol. 22, 176–182.
Serebrisky, D., Teper, A. A., Huang, C. K., et al. (2000) CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma. J. Immunol. 165, 5906–5912.
Iwamoto, I., Nakajima, H., Endo, H. and Yoshida, S. (1993) Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells. J. Exp. Med. 177, 573–576.
Gavett, S. H., O’Hearn, D. J., Li, X., Huang, S. K., Finkelman, F. D. and Wills-Karp, M. (1995) Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182, 1527–1536.
Kline, J. N., Krieg, A. M., Waldschmidt, T. J., Ballas, Z. K., Jain, V. and Businga, T. R. (1999) CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma. J. Allergy Clin. Immunol. 104, 1258–1264.
Chiaramonte, M. G., Hesse, M., Cheever, A. W. and Wynn, T. A. (2000) CpG oligonucleotides can prophylactically immunize against Th2-mediated schis- tosome egg-induced pathology by an IL-12-independent mechanism. J. Immunol. 164, 973–985.
Agranovich, I., Scott, D. E., Terle, D., Lee, K. and Golding, B. (1999) Downregulation of Th2 responses by Brucella abortus, a strong Th 1 stimulus, correlates with alterations in the B7.2-CD28 pathway. Infect. Immun. 67, 4418–4426.
Meissner, N., Kochs, S., Coutelle, J., et al. (1999) Modified T-cell activation pattern during specific immunotherapy (SIT) in cat-allergic patients. Clin. Exp. Allergy 29, 618–625.
O’Brien, R. M., Xu, H., Rolland, J. M., Byron, K. A. and Thomas, W. R. (2000) Allergen-specific production of interferon-gamma by peripheral blood mononuclear cells and CD8 T cells in allergic disease and following immunotherapy. Clin. Exp. Allergy 30, 333–340.
Hansen, G., Berry, G., DeKruyff, R. H. and Umetsu, D. T. (1999) Allergenspecific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 103, 175–183.
Randolph, D. A., Stephens, R., Carruthers, C. J. and Chaplin, D. D. (1999) Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J. Clin. Invest. 104, 1021–1029.
Wild, J. S., Sigounas, A., Sur, N., et al. (2000) IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma. J. Immunol. 164, 2701–2710.
Sun, S., Zhang, X., Tough, D. F., and Sprent, J. (1998) Type I interferonmediated stimulation of T cells by CpG DNA. J. Exp. Med. 188, 2335–2342.
Zuany-Amorim, C., Haile, S., Leduc, D., et al. (1995) Interleukin-1 o inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J. Clin. Invest. 95, 2644–2651.
Nakajima, H., Nakao, A., Watanabe, Y., Yoshida, S. and Iwamoto, I. (1994) IFN-alpha inhibits antigen-induced eosinophil and CD4+ T cell recruitment into tissue. J. Immunol. 153, 1264–1270.
Bellinghausen, I., Metz, G., Enk, A. H., Christmann, S., Knop, J. and Saloga, J. (1997) Insect venom immunotherapy induces interleukin-10 production and a Th2- to-Th 1 shift, and changes surface marker expression in venom-allergic subjects. Eur. J. Immunol. 27, 1131–1139.
Akdis, C. A., Blesken, T., Akdis, M., Wuthrich, B. and Blaser, K. (1998) Role of interleukin 10 in specific immunotherapy. J. Clin. Invest. 102, 98–106.
Haneda, K., Sano, K., Tamura, G., et al. (1999) Transforming growth factorbeta secreted from CD4(+) T cells ameliorates antigen-induced eosinophilic inflammation. A novel high- dose tolerance in the trachea. Am. J. Respir. Cell Mol. Biol. 21, 268–274.
Hartmann, G., Weiner, G. J. and Krieg, A. M. (1999) CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. USA 96, 9305–9310.
Sparwasser, T., Koch, E. S., Vabulas, R. M., et al. (1998) Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28, 2045–2054.
Behboudi, S., Chao, D., Klenerman, P. and Austyn, J. (2000) The effects of DNA containing CpG motif on dendritic cells. Immunolog’v 99 , 361–366.
Bliss, J., Van Cleave, V., Murray, K., et al. (1996) IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. J. Immunol. 156, 887–894.
Abramson, M. J., Puy, R. M. and Weiner, J. M. (1995) Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am. J. Respir. Crit. Care Med. 151, 969–974.
Creticos, P. S., Reed, C. E., Norman, P. S., et al. (1996) Ragweed immunotherapy in adult asthma. N. Engl. J. Med. 334, 501–506.
Mueller, H. L., and Lanz, M. (1969) Hyposensitization with bacterial vaccine in infectious asthma. A double- blind study and a longitudinal study. Jama 208, 1379–1383.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Kitagaki, K., Kline, J.N. (2002). CpG Oligodeoxynucleotides in Asthma. In: Raz, E. (eds) Microbial DNA and Host Immunity. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-305-7_24
Download citation
DOI: https://doi.org/10.1007/978-1-59259-305-7_24
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9728-1
Online ISBN: 978-1-59259-305-7
eBook Packages: Springer Book Archive